Liver Cirrhosis
Conditions
Brief summary
laboratory and ultrasongraphicc changes after endoscopical varices treatment
Interventions
DIAGNOSTIC_TESTLiver function tests (ALT,AST,ALBUMIN,BILIRUBIN,INR,PC,CBC)
Liver function tests will be assessed after endoscopic varisceal treatment for 6 monthes
DEVICEbiannual ultrasonography
portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.will be assessed after endoscopic varisceal treatment by using biannual ultrasonography for 6 monthes
Sponsors
Assiut University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* patients with liver cirrhosis and portal hyprtension with esophagel varisces
Exclusion criteria
* 1\. Patients with heart failure or renal failure 2. patients with COPD 3. Patients with hepato cellular carcinoma and portal vein thrombosis 4. Pregnant
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in liver function tests | 6 months | Liver function tests (ALT, AST, bilirubin,Albumin,Cbc,Prothrombin time,INR ) level (expected to be lower after endoscopic varisceal treatment (ex |
| Ultrasonographic changes | 6 months | { portal vein diameter , portal vein velocity and flow direction, volume flow in portal vein , congetive index, spleen size.(expected to be chnged after endoscopic varisceal treatment |
Countries
Egypt
Contacts
Primary Contactsalwa el gendi, professor doctor
Backup Contacthanan sharaf, assistant professor
Outcome results
None listed